Recent advances in our understanding of atopic dermatitis (AD) point to an emerging immune map involving multiple cytokine pathways. These novel cytokine targets are giving rise to the development of more effective and safer immunomodulatory therapies. In this case-based CE/CME eCourse, two experts in clinical dermatology review the immunopathophysiology of AD and current evidence-based strategies for its management. Discussion includes clinical trial evidence for novel immunomodulatory therapies, each agent’s safety profile, and best practices for proactive, patient-centered care.
Interactive, audio-enhanced slide lecture
To improve the quality of care and quality of life for patients with atopic dermatitis by applying current concepts and therapies to the management of moderate to severe disease.
After completing this activity, participants should be better able to:
- Implement patient-centered, proactive strategies for the long-term management of moderate to severe AD, including strategies to educate patients and improve adherence to treatment
- Differentiate novel and emerging therapies that target immune-mediated pathways underlying AD
- Create individualized treatment plans for patients with moderate to severe AD, based on patient and disease factors and efficacy and safety of available therapies
NPs and PAs
There are no prerequisites to participate in this activity.
CNE Credit Designation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
AAPA Credit Designation Statement
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until December 10, 2019. PAs should only claim credit commensurate with the extent of their participation.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Silverberg: advisory board/consultant: Abbvie, AnaptysBio, Asana, Dermavant, Eli Lilly, Galderma, GlaxoSmithKline, Glenmark, Incyte, Kiniksa, LEO, Menlo, Pfizer, Sanofi-Regeneron; research support: GlaxoSmithKline; speaker: Sanofi-Regeneron.
Ms Aldredge: speaker/consultant: AbbVie, Celgene, Lilly, Novartis, Sanofi, Sun Pharma, Regeneron Pharmaceuticals.
The Planning Committee for this activity included Ruth Cohen, Warren Beckman, and Annie Cheang, PharmD of Continuing Education Alliance. The members of the Planning Committee have no relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Watch the eCourse in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: December 10, 2018
Expiration date: December 10, 2019
© 2019 Practicing Clinicians Exchange. All Rights Reserved. SAPCE94418